Evidence map›Paper›PMID 26975752›Full record

ArticleScientific reports2016

Growth inhibition and apoptosis in cancer cells induced by polyphenolic compounds of Acacia hydaspica: Involvement of multiple signal transduction pathways.

Tayyaba Afsar, Janeen H Trembley, Christine E Salomon, Suhail Razak, Muhammad Rashid Khan, Khalil Ahmed

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 114 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Conjugation of triphenylantimony(V) with carvacrol against human breast cancer cells.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2022
    Article
  16. Article
  17. Root Extract of a MicropropagatedEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Tayyaba AfsarDepartment of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
Janeen H TrembleyCellular and Molecular Biochemistry Research Laboratory (151), Minneapolis VA Health Care System, Minneapolis, MN USA.
Christine E SalomonCentre for Drug Design, University of Minnesota, Minneapolis, MN USA.
Suhail RazakDepartment of Animal Sciences, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
Muhammad Rashid KhanDepartment of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
Khalil AhmedCellular and Molecular Biochemistry Research Laboratory (151), Minneapolis VA Health Care System, Minneapolis, MN USA.
Quaid-i-Azam University · PKUniversity of Minnesota · USMinneapolis VA Health Care System · US

Funding

A Novel Therapeutic Approach for Primary and Metastatic Prostate CancerR01CA150182 · NCI · UNIVERSITY OF MINNESOTA · PI AHMED, KHALIL · 2011 to 2015
$1.4M
Modulation of Apoptosis in Prostate CancerI01BX001731 · VA · MINNEAPOLIS VA MEDICAL CENTER · PI AHMED, KHALIL · 2012 to 2015
–
Mechanisms of CK2-regulated prostate cancer survival and deathI01BX003282 · VA · MINNEAPOLIS VA MEDICAL CENTER · PI AHMED, KHALIL · 2016 to 2019
–
BLRD VA I01 BX001731BLRD VA I01 BX003282NCI NIH HHS R01 CA150182NCI NIH HHS R01CA150182
6 · The paper itself

Abstract

Acacia hydaspica R. Parker is known for its medicinal uses in multiple ailments. In this study, we performed bioassay-guided fractionation of cytotoxic compounds from A. hydaspica and investigated their effects on growth and signaling activity in prostate and breast cancer cell lines. Four active polyphenolic compounds were identified as 7-O-galloyl catechin (GC), catechin (C), methyl gallate (MG), and catechin-3-O-gallate (CG). The four compounds inhibited prostate cancer PC-3 cell growth in a dose-dependent manner, whereas CG and MG inhibited breast cancer MDA-MB-231 cell growth. All tested compounds inhibited cell survival and colony growth in both cell lines, and there was evidence of chromatin condensation, cell shrinkage and apoptotic bodies. Further, acridine orange, ethidium bromide, propidium iodide and DAPI staining demonstrated that cell death occurred partly via apoptosis in both PC-3 and MDA-MB-231 cells. In PC-3 cells treatment repressed the expression of anti-apoptotic molecules Bcl-2, Bcl-xL and survivin, coupled with down-regulation of signaling pathways AKT, NFκB, ERK1/2 and JAK/STAT. In MDA-MB-231 cells, treatment induced reduction of CK2α, Bcl-xL, survivin and xIAP protein expression along with suppression of NFκB, JAK/STAT and PI3K pathways. Our findings suggest that certain polyphenolic compounds derived from A. hydaspica may be promising chemopreventive/therapeutic candidates against cancer.

Indexed as

AcaciaApoptosisbcl-X ProteinBlotting, WesternCatechinCell Line, TumorCell ProliferationCell SurvivalGallic AcidHumansInhibitor of Apoptosis ProteinsMicroscopy, FluorescenceMolecular StructureNeoplasmsNF-kappa BPhosphatidylinositol 3-Kinasesbcl-X ProteinBIRC5 protein, humanCatechincatechin gallateGallic AcidInhibitor of Apoptosis Proteinsmethyl gallateNF-kappa BPhosphatidylinositol 3-KinasesPolyphenolsProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-bcl-2SurvivinXIAP protein, humanX-Linked Inhibitor of Apoptosis Protein

Identifiers

PMID26975752
PMCPMC4791679
OpenAlexW2298678407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.